Experience

Mestastop® Solutions

• United States
• Biotechnology Research
• 1 - 100 Employee

• Founder

  • Sep 2018 - Present

  Metastasis is cancer's biggest killer; no treatment or predictive diagnostics are available. Mestastop has built three platforms, METAssay®, METVIVO®, and METVivo®, that fill these discovery and diagnostic gaps. The following has been achieved; 1. Prospective clinical study as a PoC for predictive diagnostics 2. Retrospective clinical study as a PoC for drug repurposing and in vitro to in vivo validation, with translational significance 3. Identification of rate-limiting steps of metastasis and novel first-in-class targets Exploring a novel Drug Repurposing Model to delay metastasis significantly; METGuard™ Show less



NSE India

• India
• Capital Markets
• 700 & Above Employee

• Day & Positional Trader

  • Sep 2017 - Aug 2018

  A new and different world for a scientist, but if one is willing to learn and not afraid of failing, sky is the limit. Market is the king. Helped me sustain my family, nourish my dreams and get back to Science. A new and different world for a scientist, but if one is willing to learn and not afraid of failing, sky is the limit. Market is the king. Helped me sustain my family, nourish my dreams and get back to Science.



Amgen

• United States
• Biotechnology Research
• 700 & Above Employee

• Associate Director (SARC)

  • Jan 2017 - Aug 2017

  A brief period, catering to Amgen's need for Biochemical Assays & Large Molecule Production. Role did not fit with my Career Aspirations as I was inclined to lead Drug Discovery, and this was more of Production Head. A brief period, catering to Amgen's need for Biochemical Assays & Large Molecule Production. Role did not fit with my Career Aspirations as I was inclined to lead Drug Discovery, and this was more of Production Head.



GVK BIO

• India
• Research Services
• 700 & Above Employee

• Associate Director - Collaborative Research

  • Jul 2009 - Jan 2017

  Disease Biology Leader in Inflammation and Oncology. Drug Discovery Programme Manager. Principal Scientist - April 2011 to March 2014 Associate Principal Scientist - Jul 2009 to March 2011 Was responsible for disease biology understanding in oncology and auto inflammatory diseases, worked as program leader in these therapeutic areas, conceptualizing, executing and working with a cross functional team. Invaluable learning of drug discovery from GSK, Abbvie, Takeda and Onconova. One small molecule programme went up to pre-IND stage. Three programmes went all the way to lead optimization. Show less



The Johns Hopkins University School of Medicine

• United States
• Hospitals and Health Care
• 700 & Above Employee

• Post Doctoral Scientist

  • Aug 2005 - Jun 2009

  Pioneered a method to synchronize trypanosomes for the first time, elucidated a unique mechanism of action (Eukaryotic Cell, EMBO J) Discovered a pathway for the trypanocidal effect of ethidium bromide on cattle, a 50-year old drug with an unknown mechanism.(pLOS pathogens) Pioneered a method to synchronize trypanosomes for the first time, elucidated a unique mechanism of action (Eukaryotic Cell, EMBO J) Discovered a pathway for the trypanocidal effect of ethidium bromide on cattle, a 50-year old drug with an unknown mechanism.(pLOS pathogens)



Chembiotek

• Biotechnology Research
• 100 - 200 Employee

• Research Scientist

  • Feb 2003 - Jul 2005

  Involved in building up the start-up biology facility. Was a member of the core group and participated actively in the framing of research capabilities and business development. Led a scientific team in molecular biology; cloning, site-directed mutagenesis and making stabilates of 40 GPCRs. Also assisted the cell biology group in assay development and trouble shooting. Standardized Bacterial expression system and protein purification, initiated insect cell expression system. The spectrum of discovery research was huge, It was both awe-inspiring and challenging. I realized my future lies here. Show less



Harvard Medical School

• United States
• Higher Education
• 700 & Above Employee

• Visiting Scientist

  • Dec 2002 - Jan 2003

  A brief period, trying to understand the role of T7 bacteriophage replication proteins. Abruptly ended, due to personal situation back home in India. A brief period, trying to understand the role of T7 bacteriophage replication proteins. Abruptly ended, due to personal situation back home in India.